nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLC12A1—urine—polycystic ovary syndrome	0.0421	0.0898	CbGeAlD
Bumetanide—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0332	0.0707	CbGeAlD
Bumetanide—SLC22A8—urine—polycystic ovary syndrome	0.0245	0.0521	CbGeAlD
Bumetanide—SLC12A4—embryo—polycystic ovary syndrome	0.0235	0.0502	CbGeAlD
Bumetanide—SLC12A5—pituitary gland—polycystic ovary syndrome	0.0188	0.04	CbGeAlD
Bumetanide—Tamsulosin—ADRA1D—polycystic ovary syndrome	0.0162	0.412	CrCbGaD
Bumetanide—SLC12A4—uterus—polycystic ovary syndrome	0.0159	0.0338	CbGeAlD
Bumetanide—SLC12A4—adipose tissue—polycystic ovary syndrome	0.0155	0.0331	CbGeAlD
Bumetanide—SLC12A5—endocrine gland—polycystic ovary syndrome	0.0145	0.031	CbGeAlD
Bumetanide—CA5A—endocrine gland—polycystic ovary syndrome	0.014	0.0299	CbGeAlD
Bumetanide—SLC12A4—adrenal gland—polycystic ovary syndrome	0.0139	0.0297	CbGeAlD
Bumetanide—Tamsulosin—ADRA1B—polycystic ovary syndrome	0.0138	0.351	CrCbGaD
Bumetanide—SLC12A2—adrenal cortex—polycystic ovary syndrome	0.0133	0.0284	CbGeAlD
Bumetanide—SLC12A4—female gonad—polycystic ovary syndrome	0.013	0.0277	CbGeAlD
Bumetanide—SLC12A4—endocrine gland—polycystic ovary syndrome	0.0121	0.0257	CbGeAlD
Bumetanide—SLC12A2—endometrium—polycystic ovary syndrome	0.0119	0.0253	CbGeAlD
Bumetanide—SLC12A2—pituitary gland—polycystic ovary syndrome	0.0108	0.0229	CbGeAlD
Bumetanide—SLC12A2—adipose tissue—polycystic ovary syndrome	0.0107	0.0228	CbGeAlD
Bumetanide—CFTR—female gonad—polycystic ovary syndrome	0.0102	0.0217	CbGeAlD
Bumetanide—SLC12A2—adrenal gland—polycystic ovary syndrome	0.00961	0.0205	CbGeAlD
Bumetanide—CFTR—endocrine gland—polycystic ovary syndrome	0.00949	0.0202	CbGeAlD
Bumetanide—Azotaemia—Metformin—polycystic ovary syndrome	0.00947	0.153	CcSEcCtD
Bumetanide—Tamsulosin—ADRA1A—polycystic ovary syndrome	0.00928	0.237	CrCbGaD
Bumetanide—CA14—adrenal gland—polycystic ovary syndrome	0.00898	0.0191	CbGeAlD
Bumetanide—SLC12A2—female gonad—polycystic ovary syndrome	0.00896	0.0191	CbGeAlD
Bumetanide—SLC12A2—vagina—polycystic ovary syndrome	0.00891	0.019	CbGeAlD
Bumetanide—SLC12A2—endocrine gland—polycystic ovary syndrome	0.00833	0.0178	CbGeAlD
Bumetanide—CA9—endocrine gland—polycystic ovary syndrome	0.00821	0.0175	CbGeAlD
Bumetanide—SLC10A1—endocrine gland—polycystic ovary syndrome	0.00787	0.0168	CbGeAlD
Bumetanide—Upset stomach—Metformin—polycystic ovary syndrome	0.0077	0.125	CcSEcCtD
Bumetanide—SLC22A11—endocrine gland—polycystic ovary syndrome	0.00719	0.0153	CbGeAlD
Bumetanide—SLC22A7—endocrine gland—polycystic ovary syndrome	0.00702	0.0149	CbGeAlD
Bumetanide—CA5B—adipose tissue—polycystic ovary syndrome	0.007	0.0149	CbGeAlD
Bumetanide—CA5B—adrenal gland—polycystic ovary syndrome	0.00628	0.0134	CbGeAlD
Bumetanide—CA12—endocrine gland—polycystic ovary syndrome	0.00607	0.0129	CbGeAlD
Bumetanide—Blood disorder—Metformin—polycystic ovary syndrome	0.00604	0.0979	CcSEcCtD
Bumetanide—CA5B—vagina—polycystic ovary syndrome	0.00582	0.0124	CbGeAlD
Bumetanide—CA5B—endocrine gland—polycystic ovary syndrome	0.00544	0.0116	CbGeAlD
Bumetanide—CA4—pituitary gland—polycystic ovary syndrome	0.00485	0.0103	CbGeAlD
Bumetanide—CA4—adipose tissue—polycystic ovary syndrome	0.00483	0.0103	CbGeAlD
Bumetanide—PTGS2—embryo—polycystic ovary syndrome	0.00449	0.00955	CbGeAlD
Bumetanide—CA4—adrenal gland—polycystic ovary syndrome	0.00433	0.00923	CbGeAlD
Bumetanide—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.00425	0.00905	CbGeAlD
Bumetanide—CA4—female gonad—polycystic ovary syndrome	0.00404	0.00861	CbGeAlD
Bumetanide—CA4—endocrine gland—polycystic ovary syndrome	0.00376	0.00801	CbGeAlD
Bumetanide—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00368	0.00783	CbGeAlD
Bumetanide—Dehydration—Metformin—polycystic ovary syndrome	0.00341	0.0552	CcSEcCtD
Bumetanide—Cramp muscle—Metformin—polycystic ovary syndrome	0.0033	0.0534	CcSEcCtD
Bumetanide—PTGS2—endometrium—polycystic ovary syndrome	0.00328	0.00699	CbGeAlD
Bumetanide—Pancreatitis—Metformin—polycystic ovary syndrome	0.0031	0.0503	CcSEcCtD
Bumetanide—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00303	0.0492	CcSEcCtD
Bumetanide—PTGS2—uterus—polycystic ovary syndrome	0.00302	0.00644	CbGeAlD
Bumetanide—PTGS2—pituitary gland—polycystic ovary syndrome	0.00297	0.00633	CbGeAlD
Bumetanide—PTGS2—adipose tissue—polycystic ovary syndrome	0.00296	0.0063	CbGeAlD
Bumetanide—PTGS2—adrenal gland—polycystic ovary syndrome	0.00265	0.00565	CbGeAlD
Bumetanide—PTGS2—female gonad—polycystic ovary syndrome	0.00247	0.00527	CbGeAlD
Bumetanide—PTGS2—vagina—polycystic ovary syndrome	0.00246	0.00524	CbGeAlD
Bumetanide—PTGS2—endocrine gland—polycystic ovary syndrome	0.0023	0.0049	CbGeAlD
Bumetanide—Muscle spasms—Metformin—polycystic ovary syndrome	0.00212	0.0344	CcSEcCtD
Bumetanide—Chest pain—Metformin—polycystic ovary syndrome	0.00188	0.0304	CcSEcCtD
Bumetanide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00176	0.0286	CcSEcCtD
Bumetanide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00174	0.0282	CcSEcCtD
Bumetanide—Hypotension—Metformin—polycystic ovary syndrome	0.00168	0.0273	CcSEcCtD
Bumetanide—Fatigue—Metformin—polycystic ovary syndrome	0.00155	0.0251	CcSEcCtD
Bumetanide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00147	0.0239	CcSEcCtD
Bumetanide—Urticaria—Metformin—polycystic ovary syndrome	0.00143	0.0232	CcSEcCtD
Bumetanide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00142	0.0231	CcSEcCtD
Bumetanide—Asthenia—Metformin—polycystic ovary syndrome	0.00129	0.0209	CcSEcCtD
Bumetanide—Pruritus—Metformin—polycystic ovary syndrome	0.00127	0.0206	CcSEcCtD
Bumetanide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00123	0.02	CcSEcCtD
Bumetanide—Dizziness—Metformin—polycystic ovary syndrome	0.00119	0.0193	CcSEcCtD
Bumetanide—Vomiting—Metformin—polycystic ovary syndrome	0.00114	0.0185	CcSEcCtD
Bumetanide—Rash—Metformin—polycystic ovary syndrome	0.00113	0.0184	CcSEcCtD
Bumetanide—Dermatitis—Metformin—polycystic ovary syndrome	0.00113	0.0184	CcSEcCtD
Bumetanide—Headache—Metformin—polycystic ovary syndrome	0.00113	0.0183	CcSEcCtD
Bumetanide—Nausea—Metformin—polycystic ovary syndrome	0.00107	0.0173	CcSEcCtD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000321	0.000748	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NAMPT—polycystic ovary syndrome	0.000321	0.000747	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.00032	0.000745	CbGpPWpGaD
Bumetanide—CA4—Metabolism—HSD3B2—polycystic ovary syndrome	0.00032	0.000745	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000319	0.000742	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP17A1—polycystic ovary syndrome	0.000318	0.00074	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000318	0.00074	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000318	0.000739	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP11A1—polycystic ovary syndrome	0.000317	0.000737	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AKR1C1—polycystic ovary syndrome	0.00031	0.000721	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00031	0.000721	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000308	0.000718	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HMMR—polycystic ovary syndrome	0.000304	0.000708	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.000303	0.000705	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000303	0.000705	CbGpPWpGaD
Bumetanide—CA14—Metabolism—TH—polycystic ovary syndrome	0.000302	0.000704	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AKR1C3—polycystic ovary syndrome	0.000299	0.000696	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000299	0.000696	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000295	0.000687	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—TH—polycystic ovary syndrome	0.000295	0.000686	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP17A1—polycystic ovary syndrome	0.000295	0.000686	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SLC2A4—polycystic ovary syndrome	0.000294	0.000685	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000293	0.000681	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000292	0.000679	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HSD3B1—polycystic ovary syndrome	0.00029	0.000675	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—RRM2—polycystic ovary syndrome	0.00029	0.000674	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000288	0.000671	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000287	0.000669	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000287	0.000669	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000287	0.000667	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.000287	0.000667	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000285	0.000664	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—YAP1—polycystic ovary syndrome	0.000279	0.00065	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CYP19A1—polycystic ovary syndrome	0.000277	0.000644	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000276	0.000643	CbGpPWpGaD
Bumetanide—CA4—Metabolism—RRM2—polycystic ovary syndrome	0.000276	0.000643	CbGpPWpGaD
Bumetanide—CA7—Metabolism—TH—polycystic ovary syndrome	0.000275	0.00064	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—TH—polycystic ovary syndrome	0.000275	0.00064	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000272	0.000633	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00027	0.000628	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CYP19A1—polycystic ovary syndrome	0.00027	0.000627	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NAMPT—polycystic ovary syndrome	0.000268	0.000624	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000268	0.000624	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SLC2A4—polycystic ovary syndrome	0.000268	0.000623	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000268	0.000623	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000267	0.000621	CbGpPWpGaD
Bumetanide—CA4—Metabolism—YAP1—polycystic ovary syndrome	0.000266	0.00062	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000265	0.000616	CbGpPWpGaD
Bumetanide—CA9—Metabolism—LHB—polycystic ovary syndrome	0.000265	0.000616	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000263	0.000612	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000259	0.000602	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000258	0.0006	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000256	0.000596	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NAMPT—polycystic ovary syndrome	0.000256	0.000595	CbGpPWpGaD
Bumetanide—CA12—Metabolism—TH—polycystic ovary syndrome	0.000255	0.000593	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000253	0.000588	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000252	0.000586	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP19A1—polycystic ovary syndrome	0.000252	0.000586	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000251	0.000584	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AKR1C1—polycystic ovary syndrome	0.00025	0.000583	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AKR1C3—polycystic ovary syndrome	0.00025	0.000582	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SLC2A4—polycystic ovary syndrome	0.000248	0.000577	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GNAS—polycystic ovary syndrome	0.000247	0.000575	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000246	0.000573	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000245	0.000571	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000245	0.00057	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000241	0.00056	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000241	0.00056	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GNAS—polycystic ovary syndrome	0.000241	0.00056	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.00024	0.000559	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000239	0.000555	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000238	0.000554	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000235	0.000548	CbGpPWpGaD
Bumetanide—CA14—Metabolism—NCOR1—polycystic ovary syndrome	0.000235	0.000547	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000235	0.000547	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP19A1—polycystic ovary syndrome	0.000233	0.000543	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SULT2A1—polycystic ovary syndrome	0.00023	0.000536	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—NCOR1—polycystic ovary syndrome	0.000229	0.000533	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000229	0.000533	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000228	0.000531	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GNAS—polycystic ovary syndrome	0.000225	0.000523	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GNAS—polycystic ovary syndrome	0.000225	0.000523	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000224	0.000521	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000224	0.000521	CbGpPWpGaD
Bumetanide—CA9—Metabolism—RRM2—polycystic ovary syndrome	0.000223	0.00052	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CYP1A1—polycystic ovary syndrome	0.000223	0.000519	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.00022	0.000511	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.00022	0.000511	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—STAR—polycystic ovary syndrome	0.000218	0.000507	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000218	0.000507	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CYP1A1—polycystic ovary syndrome	0.000217	0.000506	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000217	0.000505	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000215	0.000501	CbGpPWpGaD
Bumetanide—CA9—Metabolism—YAP1—polycystic ovary syndrome	0.000215	0.000501	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NCOR1—polycystic ovary syndrome	0.000214	0.000498	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NCOR1—polycystic ovary syndrome	0.000214	0.000498	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TH—polycystic ovary syndrome	0.000213	0.000496	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GNAS—polycystic ovary syndrome	0.000208	0.000484	CbGpPWpGaD
Bumetanide—CA14—Metabolism—MTHFR—polycystic ovary syndrome	0.000208	0.000484	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000207	0.000482	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NAMPT—polycystic ovary syndrome	0.000207	0.000481	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000206	0.000479	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000205	0.000476	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000204	0.000475	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000204	0.000475	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TH—polycystic ovary syndrome	0.000203	0.000473	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000203	0.000472	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP1A1—polycystic ovary syndrome	0.000203	0.000472	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—MTHFR—polycystic ovary syndrome	0.000203	0.000471	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000199	0.000464	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NCOR1—polycystic ovary syndrome	0.000198	0.000461	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000198	0.00046	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000195	0.000454	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000194	0.000452	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000193	0.000449	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP17A1—polycystic ovary syndrome	0.00019	0.000442	CbGpPWpGaD
Bumetanide—CA7—Metabolism—MTHFR—polycystic ovary syndrome	0.000189	0.00044	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—MTHFR—polycystic ovary syndrome	0.000189	0.00044	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	0.000188	0.000437	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000186	0.000433	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000186	0.000433	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000185	0.000431	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000183	0.000426	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000183	0.000425	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00018	0.000419	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000177	0.000411	CbGpPWpGaD
Bumetanide—CA12—Metabolism—MTHFR—polycystic ovary syndrome	0.000175	0.000408	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GNAS—polycystic ovary syndrome	0.000174	0.000405	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000174	0.000404	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000174	0.000404	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000174	0.000404	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000172	0.0004	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—LHB—polycystic ovary syndrome	0.000169	0.000393	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PPARG—polycystic ovary syndrome	0.000169	0.000392	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000167	0.000388	CbGpPWpGaD
Bumetanide—CA14—Metabolism—POMC—polycystic ovary syndrome	0.000166	0.000387	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GNAS—polycystic ovary syndrome	0.000166	0.000386	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NCOR1—polycystic ovary syndrome	0.000166	0.000386	CbGpPWpGaD
Bumetanide—CA14—Metabolism—INS—polycystic ovary syndrome	0.000165	0.000385	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000165	0.000384	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000164	0.000382	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PPARG—polycystic ovary syndrome	0.000164	0.000382	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TH—polycystic ovary syndrome	0.000164	0.000382	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	0.000163	0.000379	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—POMC—polycystic ovary syndrome	0.000162	0.000377	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—INS—polycystic ovary syndrome	0.000161	0.000375	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.00016	0.000372	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	0.00016	0.000372	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NCOR1—polycystic ovary syndrome	0.000158	0.000368	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000157	0.000366	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000157	0.000366	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PPARG—polycystic ovary syndrome	0.000153	0.000357	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PPARG—polycystic ovary syndrome	0.000153	0.000357	CbGpPWpGaD
Bumetanide—CA7—Metabolism—POMC—polycystic ovary syndrome	0.000151	0.000352	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—POMC—polycystic ovary syndrome	0.000151	0.000352	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000151	0.000352	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—INS—polycystic ovary syndrome	0.00015	0.00035	CbGpPWpGaD
Bumetanide—CA7—Metabolism—INS—polycystic ovary syndrome	0.00015	0.00035	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	0.00015	0.00035	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP1A1—polycystic ovary syndrome	0.00015	0.000349	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000148	0.000344	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000147	0.000342	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—MTHFR—polycystic ovary syndrome	0.000146	0.000341	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000145	0.000338	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000142	0.000332	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PPARG—polycystic ovary syndrome	0.000142	0.000331	CbGpPWpGaD
Bumetanide—CA12—Metabolism—POMC—polycystic ovary syndrome	0.00014	0.000326	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.00014	0.000326	CbGpPWpGaD
Bumetanide—CA4—Metabolism—MTHFR—polycystic ovary syndrome	0.00014	0.000325	CbGpPWpGaD
Bumetanide—CA12—Metabolism—INS—polycystic ovary syndrome	0.000139	0.000324	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000138	0.000321	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000137	0.00032	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GNAS—polycystic ovary syndrome	0.000134	0.000312	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NAMPT—polycystic ovary syndrome	0.000132	0.000307	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000132	0.000306	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000131	0.000305	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP11A1—polycystic ovary syndrome	0.00013	0.000303	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00013	0.000303	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000129	0.000301	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NCOR1—polycystic ovary syndrome	0.000128	0.000297	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000123	0.000286	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000121	0.000282	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000121	0.000282	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.00012	0.000278	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PPARG—polycystic ovary syndrome	0.000119	0.000276	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000118	0.000274	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000117	0.000273	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—POMC—polycystic ovary syndrome	0.000117	0.000273	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—INS—polycystic ovary syndrome	0.000116	0.000271	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000115	0.000268	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPARG—polycystic ovary syndrome	0.000113	0.000264	CbGpPWpGaD
Bumetanide—CA9—Metabolism—MTHFR—polycystic ovary syndrome	0.000113	0.000263	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000112	0.00026	CbGpPWpGaD
Bumetanide—CA4—Metabolism—POMC—polycystic ovary syndrome	0.000112	0.00026	CbGpPWpGaD
Bumetanide—CA4—Metabolism—INS—polycystic ovary syndrome	0.000111	0.000259	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000111	0.000257	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000107	0.000249	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000106	0.000247	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TH—polycystic ovary syndrome	0.000105	0.000244	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000105	0.000244	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000102	0.000237	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000102	0.000237	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	9.97e-05	0.000232	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GAB1—polycystic ovary syndrome	9.77e-05	0.000227	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	9.65e-05	0.000225	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP19A1—polycystic ovary syndrome	9.59e-05	0.000223	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NAMPT—polycystic ovary syndrome	9.51e-05	0.000221	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPARG—polycystic ovary syndrome	9.15e-05	0.000213	CbGpPWpGaD
Bumetanide—CA9—Metabolism—POMC—polycystic ovary syndrome	9.03e-05	0.00021	CbGpPWpGaD
Bumetanide—CA9—Metabolism—INS—polycystic ovary syndrome	8.98e-05	0.000209	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	8.88e-05	0.000207	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	8.87e-05	0.000207	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	8.74e-05	0.000203	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	8.6e-05	0.0002	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	8.56e-05	0.000199	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	8.29e-05	0.000193	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	8.15e-05	0.00019	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	7.97e-05	0.000185	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.92e-05	0.000184	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	7.87e-05	0.000183	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.81e-05	0.000182	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	7.73e-05	0.00018	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	7.48e-05	0.000174	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	7.43e-05	0.000173	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	7.35e-05	0.000171	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	7.32e-05	0.00017	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	7.2e-05	0.000168	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PRL—polycystic ovary syndrome	7.01e-05	0.000163	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TH—polycystic ovary syndrome	6.33e-05	0.000147	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	6.16e-05	0.000143	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NCOR1—polycystic ovary syndrome	5.88e-05	0.000137	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	5.84e-05	0.000136	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	5.79e-05	0.000135	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NRG1—polycystic ovary syndrome	5.77e-05	0.000134	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	5.76e-05	0.000134	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	5.73e-05	0.000133	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTHFR—polycystic ovary syndrome	5.19e-05	0.000121	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	5.17e-05	0.00012	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IRS2—polycystic ovary syndrome	4.94e-05	0.000115	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	4.92e-05	0.000115	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	4.67e-05	0.000109	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	4.35e-05	0.000101	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IRS1—polycystic ovary syndrome	4.31e-05	0.0001	CbGpPWpGaD
Bumetanide—PTGS2—Disease—INS—polycystic ovary syndrome	4.13e-05	9.62e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT2—polycystic ovary syndrome	3.99e-05	9.29e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	3.8e-05	8.83e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	3.53e-05	8.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—POMC—polycystic ovary syndrome	3.48e-05	8.1e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—INS—polycystic ovary syndrome	3.46e-05	8.05e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—polycystic ovary syndrome	1.81e-05	4.2e-05	CbGpPWpGaD
